Treatment for COVID-19

Those at lower risk for complications from COVID-19 can treat their symptoms at home in most cases. However, if you or someone you know is at higher risk for more serious illness, another option called monoclonal antibody treatment is available at early onset of COVID-19 infection.

Monoclonal Antibodies

REGEN-COV is an investigational medicine used for the treatment of COVID-19 in non-hospitalized patients who are at high risk for developing severe COVID-19 symptoms or the need for hospitalization. It is meant to be given to patients who are diagnosed with COVID-19 and are at less than 10 days of symptom onset. 

Talk with your healthcare provider about the risks and benefits of receiving the infusion to see if this treatment is right for you. To discuss scheduling an infusion appointment at Baptist Health Medical Center-Little Rock, please call (501) 202-4630.

Providers can provide the phone number of (501) 202-4630 to patients to self refer or they can complete a referral for monoclonal antibody treatment by faxing the form linked below as well as a face sheet to (501) 202-4635.

Those at lower risk for complications from COVID-19 can treat their symptoms at home in most cases. However, if you or someone you know is at higher risk for more serious illness, another option called monoclonal antibody treatment is available at early onset of COVID-19 infection.

Monoclonal Antibodies

REGEN-COV is an investigational medicine used for the treatment of COVID-19 in non-hospitalized patients who are at high risk for developing severe COVID-19 symptoms or the need for hospitalization. It is meant to be given to patients who are diagnosed with COVID-19 and are at less than 10 days of symptom onset. 

Talk with your healthcare provider about the risks and benefits of receiving the infusion to see if this treatment is right for you. To discuss scheduling an infusion appointment at Baptist Health Medical Center-Little Rock, please call (501) 202-4630.

Providers can provide the phone number of (501) 202-4630 to patients to self refer or they can complete a referral for monoclonal antibody treatment by faxing the form linked below as well as a face sheet to (501) 202-4635.

Learn More About Monoclonal Antibody Treatment

Dr. Dirk Haselow, system epidemiologist and associate medical director of infection prevention at Baptist Health, explains REGEN-COV.

Frequently Asked Questions

Monoclonal antibodies target a specific virus or bacteria. They attach to the virus to block it from entering human cells, and the monoclonal antibody protein also helps eliminate or clear the virus from the body.

REGEN-COV has received emergency use authorization from the Food and Drug Administration (FDA) for the treatment or post-exposure prevention of COVID-19.

Adults with risk factors for severe disease, who have tested positive for COVID-19 and have had symptoms for less than 10 days could be candidates for this infusion. Any patient under the age of 18 is not eligible to receive monoclonal antibody treatment at Baptist Health. REGEN-COV is not authorized for patients with an increased O2 requirement.

High-risk categories include:

  • Overweight (Body mass index > 25)
  • Pregnancy
  • Sickle cell disease
  • Chronic kidney disease
  • Diabetes mellitus
  • Immunosuppressive disease (Cancer, Autoimmune Disease, etc)
  • Currently receiving immunosuppressive Treatment
  • 65 years of age or older
  • Cardiovascular disease (high blood pressure, heart disease, etc)
  • COPD/other chronic respiratory disease (asthma, etc)
  • Neurodevelopmental Disorder
  • Medical related dependence (tracheostomy, PEG, etc)

Other risk factors include race, ethnicity and history of tobacco use. 

Monoclonal antibody treatment is administered as a one-time IV infusion of REGEN-COV (casirivimab and imdevimab) or it can be given as four subcutaneous injections.

Some recipients of monoclonal antibody infusion may experience short-term side effects such as nausea and dizziness. Mild-to-severe allergic reactions are possible but uncommon. If you experience new or worsening symptoms after infusion, seek immediate medical attention.

According to the Food and Drug Administration (FDA), the benefit of receiving REGEN-COV may be greater than the risk of using the treatment. If you are pregnant or breastfeeding, speak with your healthcare provider about your options.

The medication is free of charge, however, there is a cost to administer the treatment. Fees will be billed to a patient’s insurance provider. Check with your insurance provider for more information. The out-of-pocket cost for treatment at Baptist Health Medical Center-Little Rock is $292.50.

Per the Centers for Disease Control and Prevention (CDC), COVID-19 vaccination should be deferred for at least 90 days after receiving monoclonal antibody infusion.

Monoclonal Antibody Treatment Locations

For a full list of locations offering monoclonal antibody treatment for COVID-19, visit the Arkansas Department of Health website.

For more information on COVID-19, visit the Baptist Health Coronavirus Information Hub.